Cancer Channel
Related Channels


Were you looking for information about Ontak? Ontack is a common misspelling of Ontak.
Ontak® (denileukin diftitox) is prescribed to treat cutaneous T-cell lymphoma, a type of non-Hodgkin's lymphoma that usually begins in certain white blood cells found in the skin. This medication is given as an intravenous (IV) injection for five days in a row, once every three weeks.
Although some people may not have any problems with this medicine, side effects are possible and may include nausea, fatigue, and diarrhea. People who have a history of low albumin levels, certain allergies, or certain other medical problems may not be able to safely use Ontak.
(For more information on this medicine, click Ontak. This full-length article offers a complete overview of this drug, including how it works, safety warnings, and general dosing instructions. You can also click any of the links in the box to the right for specific information.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.